Visiongain Publishes Biopharmaceuticals Contract Manufacturing Market Report 2020-2030

News provided by

Apr 15, 2020, 05:00 ET

LONDON, April 15, 2020 /PRNewswire/ -- Forecasts by Service (Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & Quality Control Studies, Packaging), by Product (Biologics (Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Insulin), Biosimilars) Plus Analysis of Leading Companies

Market Dynamics

Continuing expansion of biopharmaceutical manufacturing capacity by CDMOs/CMOs
Increasing outsourcing of biopharmaceuticals-related manufacturing activities
Increasing demand for fill-finish services in biopharmaceutical contract manufacturing market
Increasing productivity and efficiency of biopharmaceuticals manufacturing processes
Uptake of single-use production systems by the biopharmaceutical manufacturing industry
Asia emerging as hot destination for biopharmaceutical manufacturing
Increasing confidence of pharmaceutical industry in CDMOs capabilities
High level of outsourcing of manufacturing newly approved drugs by smaller biotech companies is fuelling the growth of biopharma-specific CMOs/CDMOs
Higher acceptance and success of biopharmaceutical products in the market provides tremendous opportunities to biopharmaceuticals contract manufacturers
Increasing shortage of skilled workforce in the biopharmaceutical industry
Expensive manufacturing equipment requirements and complex processes raise barriers to entry, which is limiting market growth
Complicated and stringent regulatory requirements hinder market growth

To request sample pages from this report please contact Sara Peerun at [email protected] or refer to our website: https://www.visiongain.com/report/biopharmaceuticals-contract-manufacturing-market-report-2020-2030/#download_sampe_div

Market Segmentation 2020-2030

Biopharmaceuticals Contract Manufacturing Market is segmented on the Service, Product, and Regional basis.

Service

• Process Development
– Downstream
– Upstream

• Fill & Finish Operations
• Analytical & Quality Control Studies
• Packaging

Product

• Biologics
– Monoclonal Antibodies (MAbs)
– Recombinant Proteins
– Vaccines
– Insulin

• Biosimilars

Regional Breakdown

Focused regional forecasts and analysis explore the future opportunities:

• North America
– U.S.
– Canada

• Europe
– UK
– France
– Germany
– Russia
– Rest of Europe

• Asia-Pacific
– China
– Japan
– India
– Southeast Asia
– Rest of Asia Pacific

• Latin America
– Brazil
– Argentina
– Rest of Latin America

• Middle East & Africa
– GCC
– South Africa
– Rest of Middle East

Did you know that we also offer a report add-on service? Email [email protected] to discuss any customized research needs you may have.

Companies covered in the report include:

AbbVie, Inc.
AGC Biologics
Binex Co., Ltd.
Boehringer Ingelheim International GmbH
FUJIFILM Diosynth Biotechnologies
Inno Bio Ventures
JRS PHARMA
Lonza
ProBioGen
Rentschler Biotechnologie GmbH
Samsung BioLogics
Sandoz
Thermo Fisher Scientific Inc.
TOYOBO CO., LTD.
WuXi Biologics